Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

LENZ Therapeutics

休市中 08-23 16:00:00 EDT

22.50

+0.28

+1.26%

盘后22.50

+0.000.00%

16:09 EDT

最高22.68	最低21.85	成交量6.32万
今开22.54	昨收22.22	日振幅3.71%
总市值6.19亿	流通市值2.77亿	总股本2,750万
成交额141.64万	换手率0.51%	流通股本1,232万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"LENZ","market":"US","secType":"STK","nameCN":"Therapeutics","latestPrice":22.5,"timestamp":1724443200000,"preClose":22.22,"halted":0,"volume":63152,"hourTrading":{"tag":"盘后","latestPrice":22.5,"preClose":22.5,"latestTime":"16:09 EDT","volume":2565,"amount":57712.5,"timestamp":1724443782737},"delay":0,"floatShares":12319561,"shares":27496665,"eps":-4.263813,"marketStatus":"休市中","marketStatusCode":7,"change":0.28,"latestTime":"08-23 16:00:00 EDT","open":22.54,"high":22.675,"low":21.85,"amount":1416427.68248,"amplitude":0.037129,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.263813,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1724659200000},"adr":0,"listingDate":1624593600000,"adjPreClose":22.22,"postHourTrading":{"tag":"盘后","latestPrice":22.5,"preClose":22.5,"latestTime":"16:09 EDT","volume":2565,"amount":57712.5,"timestamp":1724443782737},"volumeRatio":0.7287750263983267},"requestUrl":"/m/hq/s/LENZ","defaultTab":"news","newsList":[{"id":"2461541130","title":"Lisata Therapeutics, Inc.盘中异动 快速上涨6.59%报3.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461541130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461541130?lang=zh_cn&edition=full","pubTime":"2024-08-24 02:46","pubTimestamp":1724438789,"startTime":"0","endTime":"0","summary":"北京时间2024年08月24日02时46分，Lisata Therapeutics, Inc.股票出现波动，股价急速上涨6.59%。Lisata Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。Lisata Therapeutics, Inc.公司简介：Lisata Therapeutics Inc是一家临床阶段的生物制药公司，致力于发现、开发和商业化用于治疗晚期实体瘤和其他重大疾病的创新疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082402462998e361cc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082402462998e361cc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","LSTA"],"gpt_icon":0},{"id":"2461451545","title":"Qualigen Therapeutics, Inc.盘中异动 下午盘快速跳水5.05%报0.199美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461451545","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461451545?lang=zh_cn&edition=full","pubTime":"2024-08-24 01:42","pubTimestamp":1724434940,"startTime":"0","endTime":"0","summary":"北京时间2024年08月24日01时42分，Qualigen Therapeutics, Inc.股票出现异动，股价大幅下跌5.05%。Qualigen Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。其相关个股中，Portage Biotech Inc.、Theriva Biologics, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Portage Biotech Inc.、Virax Biolabs Group Limited、Elevai Labs, Inc.较为活跃，换手率分别为4274.72%、220.64%、160.31%，振幅较大的相关个股有Portage Biotech Inc.、Theriva Biologics, Inc.、Anew Medical Inc C/Wts 21/06/2029 ，振幅分别为162.20%、76.86%、72.14%。Qualigen Therapeutics, Inc.公司简介：Qualigen Therapeutics Inc 是一家早期临床治疗公司，致力于开发成人和儿童癌症的治疗方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082401422198e361bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082401422198e361bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QLGN","BK4139","LENZ"],"gpt_icon":0},{"id":"2461016548","title":"Intellia Therapeutics, Inc.盘中异动 股价大涨5.04%报24.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461016548","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461016548?lang=zh_cn&edition=full","pubTime":"2024-08-24 01:05","pubTimestamp":1724432726,"startTime":"0","endTime":"0","summary":"北京时间2024年08月24日01时05分，Intellia Therapeutics, Inc.股票出现异动，股价急速拉升5.04%。Intellia Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Intellia Therapeutics, Inc.公司简介：Intellia Therapeutics 是一家基因编辑公司，致力于开发基于 Crispr/Cas9 的疗法。Intellia 致力于利用这项技术治疗基因定义的疾病。Intellia 已与多家公司建立了合作关系，以推进其产品线的发展，其中包括窄膜 Regeneron 和宽膜 Novartis。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240824010526ab5f70b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240824010526ab5f70b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4588","LU1861559042.SGD","BK4535","LENZ","BK4585","NTLA","BK4556","LU1861558580.USD"],"gpt_icon":0},{"id":"2461515815","title":"Briacell Therapeutics Corp.盘中异动 快速上涨7.32%报0.880美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461515815","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461515815?lang=zh_cn&edition=full","pubTime":"2024-08-23 22:30","pubTimestamp":1724423423,"startTime":"0","endTime":"0","summary":"北京时间2024年08月23日22时30分，Briacell Therapeutics Corp.股票出现异动，股价急速上涨7.32%。截至发稿，该股报0.880美元/股，成交量12.8407万股，换手率0.70%，振幅6.46%。Briacell Therapeutics Corp.股票所在的生物技术行业中，整体涨幅为0.58%。Briacell Therapeutics Corp.公司简介：BriaCell Therapeutics Corp是一家专注于免疫肿瘤学的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240823223024a1d6037b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240823223024a1d6037b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BCTX","BK4139","LENZ"],"gpt_icon":0},{"id":"2461481513","title":"Esperion Therapeutics, Inc.盘中异动 早盘股价大涨5.26%报1.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461481513","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461481513?lang=zh_cn&edition=full","pubTime":"2024-08-23 22:26","pubTimestamp":1724423212,"startTime":"0","endTime":"0","summary":"北京时间2024年08月23日22时26分，Esperion Therapeutics, Inc.股票出现异动，股价急速上涨5.26%。截至发稿，该股报1.80美元/股，成交量83.1051万股，换手率0.42%，振幅4.39%。Esperion Therapeutics, Inc.股票所在的制药行业中，整体跌幅为0.07%。其相关个股中，Guardion Health Sciences, Inc.、Evotec Se、Organogenesis Holdings Inc.涨幅较大，Guardion Health Sciences, Inc.、Painreform Ltd.、苏轩堂较为活跃，换手率分别为7.90%、5.12%、3.70%，振幅较大的相关个股有Guardion Health Sciences, Inc.、Bright Green Corporation、Scilex Holding Company C/Wts 10/11/2027 ，振幅分别为12.00%、11.33%、9.90%。Esperion Therapeutics, Inc.公司简介：Esperion Therapeutics Inc 是一家制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082322265298e360a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082322265298e360a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","LENZ","ESPR"],"gpt_icon":0},{"id":"2461971495","title":"Seres Therapeutics, Inc.盘中异动 急速上涨5.08%报0.904美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461971495","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461971495?lang=zh_cn&edition=full","pubTime":"2024-08-23 22:05","pubTimestamp":1724421914,"startTime":"0","endTime":"0","summary":"北京时间2024年08月23日22时05分，Seres Therapeutics, Inc.股票出现异动，股价急速上涨5.08%。截至发稿，该股报0.904美元/股，成交量5.5608万股，换手率0.04%，振幅3.70%。Seres Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.67%。Seres Therapeutics, Inc.公司简介：Seres Therapeutics Inc 是一家在美国运营的微生物治疗平台公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082322051498e36055&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082322051498e36055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","MCRB","BK4139"],"gpt_icon":0},{"id":"2461597083","title":"Aquestive Therapeutics, Inc.盘中异动 大幅拉升5.10%报4.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461597083","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461597083?lang=zh_cn&edition=full","pubTime":"2024-08-23 22:05","pubTimestamp":1724421906,"startTime":"0","endTime":"0","summary":"北京时间2024年08月23日22时05分，Aquestive Therapeutics, Inc.股票出现波动，股价大幅上涨5.10%。截至发稿，该股报4.53美元/股，成交量7.0156万股，换手率0.08%，振幅4.64%。Aquestive Therapeutics, Inc.股票所在的制药行业中，整体涨幅为0.19%。Aquestive Therapeutics, Inc.公司简介：Aquestive Therapeutics Inc 是一家专业制药公司，致力于开发和商业化差异化产品以满足医疗需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082322050698e36053&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082322050698e36053&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","AQST","LENZ"],"gpt_icon":0},{"id":"2461592963","title":"Virios Therapeutics, Inc.盘中异动 快速下挫5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461592963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461592963?lang=zh_cn&edition=full","pubTime":"2024-08-23 21:32","pubTimestamp":1724419958,"startTime":"0","endTime":"0","summary":"北京时间2024年08月23日21时32分，Virios Therapeutics, Inc.股票出现波动，股价快速跳水5.10%。Virios Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。其相关个股中，Portage Biotech Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Seastar Medical Holding Corp C/Wts 28/10/2027 涨幅较大，Portage Biotech Inc.、Elevai Labs, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃，换手率分别为324.53%、130.09%、62.34%，振幅较大的相关个股有Portage Biotech Inc.、Cingulate Inc C/Wts 10/12/2026 、Elevai Labs, Inc.，振幅分别为36.66%、16.10%、15.60%。Virios Therapeutics, Inc.公司简介：Virios Therapeutics Inc是一家处于发展阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240823213238ab5f68cf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240823213238ab5f68cf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VIRI","LENZ","BK4139"],"gpt_icon":0},{"id":"2461930552","title":"肿瘤生物技术公司Bicara Therapeutics(BCAX.US)申请IPO 拟筹资2亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461930552","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461930552?lang=zh_cn&edition=full","pubTime":"2024-08-23 17:02","pubTimestamp":1724403735,"startTime":"0","endTime":"0","summary":"Bicara Therapeutics向SEC提交了首次公开募股(IPO)申请，计划融资2亿美元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20240823/20240823170239_37012.png?x-oss-process=image/format,jpg/quality,Q_80&image_source=-1","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240823/20240823170239_37012.png?x-oss-process=image/format,jpg/quality,Q_80&image_source=-1"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1169373.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4139","LENZ"],"gpt_icon":0},{"id":"2461320038","title":"Windtree Therapeutics, Inc.盘中异动 临近收盘快速拉升5.12%报11.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461320038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461320038?lang=zh_cn&edition=full","pubTime":"2024-08-23 03:53","pubTimestamp":1724356407,"startTime":"0","endTime":"0","summary":"北京时间2024年08月23日03时53分，Windtree Therapeutics, Inc.股票出现波动，股价快速上涨5.12%。Windtree Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Windtree Therapeutics, Inc.公司简介：Windtree Therapeutics Inc是一家处于开发阶段的生物技术公司，专注于开发用于呼吸系统疾病的KL4表面活性剂疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082303532797199ad7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082303532797199ad7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["WINT","WINTW","BK4139","LENZ"],"gpt_icon":0},{"id":"2461200533","title":"Crispr Therapeutics Ag盘中异动 临近收盘快速下跌5.05%报47.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461200533","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461200533?lang=zh_cn&edition=full","pubTime":"2024-08-23 03:53","pubTimestamp":1724356397,"startTime":"0","endTime":"0","summary":"北京时间2024年08月23日03时53分，Crispr Therapeutics Ag股票出现异动，股价大幅下跌5.05%。截至发稿，该股报47.47美元/股，成交量87.9027万股，换手率1.03%，振幅4.99%。Crispr Therapeutics Ag股票所在的生物技术行业中，整体涨幅为0.09%。Crispr Therapeutics Ag公司简介：Crispr Therapeutics是一家基因编辑公司，专注于开发基于CRISPR/Cas9的疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082303531798e35e8b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082303531798e35e8b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4588","LU1861559042.SGD","LU1861558580.USD","BK4556","BK4139","CRSP","BK4585"],"gpt_icon":0},{"id":"2461322970","title":"Lyra Therapeutics, Inc.盘中异动 急速下挫5.91%报0.315美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461322970","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461322970?lang=zh_cn&edition=full","pubTime":"2024-08-23 02:50","pubTimestamp":1724352643,"startTime":"0","endTime":"0","summary":"北京时间2024年08月23日02时50分，Lyra Therapeutics, Inc.股票出现波动，股价大幅跳水5.91%。Lyra Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Lyra Therapeutics, Inc.公司简介：Lyra Therapeutics Inc 是一家临床阶段的治疗公司，专注于新型综合药物和给药解决方案的开发和商业化，用于耳鼻喉疾病患者的局部治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082302504398e35e6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082302504398e35e6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","BK4007","LYRA"],"gpt_icon":0},{"id":"2461321060","title":"Iterum Therapeutics Plc盘中异动 急速跳水5.75%报1.23美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461321060","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461321060?lang=zh_cn&edition=full","pubTime":"2024-08-23 02:36","pubTimestamp":1724351817,"startTime":"0","endTime":"0","summary":"北京时间2024年08月23日02时36分，Iterum Therapeutics Plc股票出现异动，股价急速下挫5.75%。截至发稿，该股报1.23美元/股，成交量12.1376万股，换手率0.53%，振幅8.81%。Iterum Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.14%。Iterum Therapeutics Plc公司简介：Iterum Therapeutics PLC 是一家临床阶段的制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082302365797199abb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082302365797199abb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ITRM","LENZ","BK4007"],"gpt_icon":0},{"id":"2461534704","title":"Tenax Therapeutics, Inc.2024财年第二财季实现净利润-3.58百万美元，同比减少222.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2461534704","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461534704?lang=zh_cn&edition=full","pubTime":"2024-08-23 00:00","pubTimestamp":1724342457,"startTime":"0","endTime":"0","summary":"8月23日，Tenax Therapeutics, Inc.公布财报，公告显示公司2024财年第二财季净利润为-3.58百万美元，同比减少222.52%；其中营业收入为0.00美元，每股基本收益为-1.83美元。从资产负债表来看，Tenax Therapeutics, Inc.总负债1.74百万美元，其中短期债务278802.00美元，资产负债比为6.11，流动比率为6.11。机构评级：截至2024年8月23日，当前有2家机构对Tenax Therapeutics, Inc.目标价做出预测，其中目标均价为32.50美元，其中最低目标价为30.00美元，最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082300011295b4b13d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082300011295b4b13d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TENX","LENZ"],"gpt_icon":0},{"id":"2461412943","title":"Adaptimmune Therapeutics Plc盘中异动 早盘快速上涨5.04%报1.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461412943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461412943?lang=zh_cn&edition=full","pubTime":"2024-08-22 23:12","pubTimestamp":1724339542,"startTime":"0","endTime":"0","summary":"北京时间2024年08月22日23时12分，Adaptimmune Therapeutics Plc股票出现异动，股价快速上涨5.04%。截至发稿，该股报1.25美元/股，成交量57.9399万股，换手率0.23%，振幅6.72%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.27%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082223122397199a6e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024082223122397199a6e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP","BK4139"],"gpt_icon":0},{"id":"2461234947","title":"Kintara Therapeutics, Inc.盘中异动 早盘快速拉升5.46%报0.234美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461234947","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461234947?lang=zh_cn&edition=full","pubTime":"2024-08-22 22:50","pubTimestamp":1724338220,"startTime":"0","endTime":"0","summary":"北京时间2024年08月22日22时50分，Kintara Therapeutics, Inc.股票出现异动，股价急速拉升5.46%。Kintara Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Biomea Fusion, Inc.涨幅较大，Virax Biolabs Group Limited、Geovax Labs, Inc.、Revelation Biosciences, Inc.较为活跃，换手率分别为330.51%、158.51%、127.43%，振幅较大的相关个股有Revelation Biosciences Inc C/Wts 10/01/2027 、Geovax Labs Inc C/Wts 29/09/2025、居里，振幅分别为67.18%、40.84%、37.17%。Kintara Therapeutics, Inc.公司简介：Kintara Therapeutics Inc从事针对医疗需求未得到满足的患者的新型癌症疗法的开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822225020a1d5be39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822225020a1d5be39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","KTRA","DMPWW","BK4139"],"gpt_icon":0},{"id":"2461334672","title":"BUZZ-Cognition Therapeutics 因阿尔茨海默氏症中期研究的积极结果而上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2461334672","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461334672?lang=zh_cn&edition=full","pubTime":"2024-08-22 22:48","pubTimestamp":1724338110,"startTime":"0","endTime":"0","summary":"** 该研究招募了16名轻度至中度阿尔茨海默病成人患者 ** 包括盘中走势在内，该股今年累计下跌 57.9","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4139","CGTX","LENZ","BUZZ"],"gpt_icon":0},{"id":"2461481563","title":"Monte Rosa Therapeutics, Inc.盘中异动 大幅跳水5.16%报6.19美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461481563","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461481563?lang=zh_cn&edition=full","pubTime":"2024-08-22 21:43","pubTimestamp":1724334208,"startTime":"0","endTime":"0","summary":"北京时间2024年08月22日21时43分，Monte Rosa Therapeutics, Inc.股票出现波动，股价急速下挫5.16%。Monte Rosa Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.29%。Monte Rosa Therapeutics, Inc.公司简介：Monte Rosa Therapeutics Inc 是一家生物技术公司，专门开发分子胶降解剂，这是一类利用人体天然蛋白质破坏机制选择性降解治疗相关蛋白质的小分子药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822214328a1d5ba82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240822214328a1d5ba82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GLUE","BK4139","LENZ","BK4539"],"gpt_icon":0},{"id":"2461710310","title":"Virios Therapeutics, Inc.盘中异动 早盘快速下挫7.00%报0.210美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2461710310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461710310?lang=zh_cn&edition=full","pubTime":"2024-08-22 21:32","pubTimestamp":1724333541,"startTime":"0","endTime":"0","summary":"北京时间2024年08月22日21时32分，Virios Therapeutics, Inc.股票出现波动，股价大幅跳水7.00%。Virios Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.43%。其相关个股中，Anew Medical Inc C/Wts 21/06/2029 、Seastar Medical Holding Corp C/Wts 28/10/2027 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Virax Biolabs Group Limited、Revelation Biosciences, Inc.、Geovax Labs, Inc.较为活跃，换手率分别为138.06%、56.40%、50.56%，振幅较大的相关个股有Revelation Biosciences Inc C/Wts 10/01/2027 、Virax Biolabs Group Limited、Galmed Pharmaceuticals Ltd.，振幅分别为52.51%、10.16%、8.93%。Virios Therapeutics, Inc.公司简介：Virios Therapeutics Inc是一家处于发展阶段的生物技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408222132219f483641&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408222132219f483641&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","VIRI","BK4139"],"gpt_icon":0},{"id":"2461318855","title":"BUZZ-与拉斐尔控股公司达成合并协议后，Cyclo Therapeutics 公司股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2461318855","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2461318855?lang=zh_cn&edition=full","pubTime":"2024-08-22 19:25","pubTimestamp":1724325938,"startTime":"0","endTime":"0","summary":"    8月22日 - ** 药物开发商Cyclo Therapeutics   股价盘前下跌23.02%至97美分** 该公司称已与 Rafael Holdings     签订了合并协议，将两家公司合并。** 48 周中期分析结果预计将于 2025 年中期公布** 合并完成后，拉斐尔控股将向CYTH股东发行B类普通股，交换比率为CYTH股票估值95美分/股，拉斐尔控股估值为现金价值加上有价证券和其他一些投资的价值减去某些流动负债。** 交易预计在 2024 年底完成** 截至上次收盘，CYTH 累计下跌约 21","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CYTH","BUZZ","BK4233","BK4205","BK4139","LENZ","RFL"],"gpt_icon":0}],"profile":{"websiteUrl":"http://lenz-tx.com","stockEarnings":[{"period":"1week","weight":-0.011},{"period":"1month","weight":-0.0442},{"period":"3month","weight":0.4331},{"period":"6month","weight":0.0714},{"period":"1year","weight":0.362},{"period":"ytd","weight":0.2268}],"compareEarnings":[{"period":"1week","weight":0.0141},{"period":"1month","weight":0.0386},{"period":"3month","weight":0.0617},{"period":"6month","weight":0.1069},{"period":"1year","weight":0.2867},{"period":"ytd","weight":0.1827}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"LENZ Therapeutics, Inc.于2017年6月1日加拿大安大略省注册成立，并于2019年10月在特拉华州重新注册。他们是一家临床阶段的下一代基因编辑公司，利用高效靶向基因整合开发新型疗法有可能治愈范围广泛的严重和危及生命的疾病。他们正在开创一种精确的基因编辑方法，以实现医学上最难以实现的目标之一：精确“找到并替换”基因组中的任何基因。他们的下一代基因编辑平台使他们能够精确地纠正突变，用正常基因替换整个致病基因，或将新基因插入预定的安全位置。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.187611},{"month":2,"riseRate":0.666667,"avgChangeRate":0.15153},{"month":3,"riseRate":0,"avgChangeRate":-0.19103},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.06634},{"month":5,"riseRate":0,"avgChangeRate":-0.187229},{"month":6,"riseRate":0.666667,"avgChangeRate":0.07217},{"month":7,"riseRate":0.5,"avgChangeRate":0.062427},{"month":8,"riseRate":0.25,"avgChangeRate":-0.062695},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.028796},{"month":10,"riseRate":0.666667,"avgChangeRate":-0.037137},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.124883},{"month":12,"riseRate":0.666667,"avgChangeRate":0.157581}],"exchange":"NASDAQ","name":"Therapeutics","nameEN":"Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Therapeutics(LENZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Therapeutics,LENZ,Therapeutics股票,Therapeutics股票老虎,Therapeutics股票老虎国际,Therapeutics行情,Therapeutics股票行情,Therapeutics股价,Therapeutics股市,Therapeutics股票价格,Therapeutics股票交易,Therapeutics股票购买,Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Therapeutics(LENZ)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Therapeutics(LENZ)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}